SCHEMBL3225595

SCHEMBL3225595

COc1nc(N2CCC(C(=O)O)CC2)c(C#N)cc1C(=O)Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 6/20 0.52
KDM4E B2RXH2 8/20 0.46
ALDH1A1 P00352 7/20 0.46
HPGD P15428 4/20 0.46
MAPK1 P28482 3/20 0.46
CASP1 P29466 3/20 0.46
HSD17B10 Q99714 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
GAA P10253 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 2/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.44
CASP7 P55210 2/20 0.43
USP2 O75604 2/20 0.43
CYP2C9 P11712 2/20 0.42
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3234102 0.87 ALDH1A1 (0.47) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL3329682 0.85 P2RY12 (0.49) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL3329418 0.85 P2RY12 (0.49) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL3328020 0.85 P2RY12 (0.57) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL3232612 0.85 P2RY12 (0.69) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL3229339 0.85 ALDH1A1 (0.58) P2RY12KDM4EALDH1A1MAPK1KMT2A
SCHEMBL3223767 0.79 P2RY12 (0.49) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL4881773 0.79 KDM4E (0.72) P2RY12KDM4EALDH1A1MAPK1GAA
SCHEMBL3942186 0.76 P2RY12 (0.40) P2RY12KDM4EALDH1A1HPGDMAPK1
SCHEMBL4115190 0.75 P2RY12 (0.70) P2RY12KDM4EALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005384-A1 KETONE PYRIDINE ANALOGUES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS ASTRAZENECA AB (SE) 2010-01-14 WO disclosed